Application 1103
Fetal Fibronectin test for Preterm Labour
Fetal Fibronectin test for Preterm Labour
| Application No. | 1103 |
| Application Name | Fetal fibronectin test for preterm labour |
| Advisory Panels | Dr Ewa Piejko (Chair and MSAC member) Professor Syd Bell (MSAC member) Professor Lesley Barclay (Royal College of Nursing, Australia nominee) Dr Fiona Cullinane (Royal Australian and New Zealand College of Obstetricians and Gynaecologists nominee) Dr Steven Kan (Royal Australian College of General Practitioners nominee) Ms Diane Walsh (Consumers' Health Forum of Australia nominee) |
| Date Received by MSAC Secretariat | October 2005 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | This assessment was considered by the MSAC at the 15 November 2006 meeting MSAC assessed the evidence for the use of fetal fibronectin testing in women who are at high risk of preterm labour to predict their risk of preterm delivery and the evidence pertaining to the use of fetal fibronectin testing for predicting preterm labour in women who: Present with symptoms suggestive of preterm labour; Singleton or twin gestation; From 24 to 33 weeks 6 days gestation; With intact amniotic membranes; and Cervical dilation <3cm; and determined that the test is safe but effectiveness has not been demonstrated. MSAC does not support public funding for this test at this time. |
| Stage 4 - Decision | Endorsed by the Minister for Health and Ageing on 5 February 2007. |
| Stage 5 - Implementation |  |
